[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS2150B - Statín-karboxýalkýleter-blöndur - Google Patents

Statín-karboxýalkýleter-blöndur

Info

Publication number
IS2150B
IS2150B IS5445A IS5445A IS2150B IS 2150 B IS2150 B IS 2150B IS 5445 A IS5445 A IS 5445A IS 5445 A IS5445 A IS 5445A IS 2150 B IS2150 B IS 2150B
Authority
IS
Iceland
Prior art keywords
carboxylalkylether
statins
mixtures
carboxylalkylether mixtures
Prior art date
Application number
IS5445A
Other languages
English (en)
Other versions
IS5445A (is
Inventor
Larry Bisgaier Charles
Schofield Newton Roger
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of IS5445A publication Critical patent/IS5445A/is
Publication of IS2150B publication Critical patent/IS2150B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5445A 1997-12-12 2000-04-14 Statín-karboxýalkýleter-blöndur IS2150B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12
PCT/US1998/024679 WO1999030704A1 (en) 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations

Publications (2)

Publication Number Publication Date
IS5445A IS5445A (is) 2000-04-14
IS2150B true IS2150B (is) 2006-10-13

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5445A IS2150B (is) 1997-12-12 2000-04-14 Statín-karboxýalkýleter-blöndur

Country Status (30)

Country Link
EP (1) EP1045691B1 (is)
JP (1) JP2002508320A (is)
KR (1) KR20010033003A (is)
AR (1) AR017851A1 (is)
AT (1) ATE285762T1 (is)
AU (1) AU754089B2 (is)
BR (1) BR9813542A (is)
CA (1) CA2304612A1 (is)
CO (1) CO4970816A1 (is)
CR (1) CR5926A (is)
CU (1) CU20000140A7 (is)
DE (1) DE69828442T2 (is)
DK (1) DK1045691T3 (is)
ES (1) ES2230733T3 (is)
GT (1) GT199800196A (is)
HN (1) HN1998000185A (is)
HU (1) HUP0004547A3 (is)
IL (1) IL135349A0 (is)
IS (1) IS2150B (is)
MY (1) MY118381A (is)
NO (1) NO20002966L (is)
NZ (1) NZ503982A (is)
PA (1) PA8464601A1 (is)
PE (1) PE20000017A1 (is)
PL (1) PL341066A1 (is)
PT (1) PT1045691E (is)
SV (1) SV1998000146A (is)
UY (1) UY25299A1 (is)
WO (1) WO1999030704A1 (is)
ZA (1) ZA9811348B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010033017A (ko) * 1997-12-12 2001-04-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 과지질혈증 치료제인 스타틴-LP(a) 억제제의 병용 제제
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
EE200100199A (et) * 1998-09-30 2002-06-17 Warner-Lambert Company Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (is) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
JP4750995B2 (ja) 2000-01-25 2011-08-17 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー カルシウムジカルボキシレートエーテル、その製造法、及びそれを用いた血管系疾患及び糖尿病の治療
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
CN1426299A (zh) * 2000-04-26 2003-06-25 沃尼尔·朗伯公司 抗高血压剂和用途
US6689807B1 (en) 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
US6777552B2 (en) 2001-08-16 2004-08-17 Teva Pharmaceutical Industries, Ltd. Processes for preparing calcium salt forms of statins
HUP0500616A3 (en) * 2001-08-16 2011-07-28 Teva Pharma Processes for preparing calcium salt forms of statins
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
WO2013103842A1 (en) * 2012-01-06 2013-07-11 Michigan Life Therapeutics, Llc Methods of reducing risk of cardiovascular disease
MX2018005540A (es) * 2015-11-06 2018-11-09 Gemphire Therapeutics Inc Tratamiento de dislipemia mixta.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
UY25299A1 (es) 2001-08-27
ZA9811348B (en) 1999-06-14
HUP0004547A3 (en) 2001-12-28
IL135349A0 (en) 2001-05-20
NZ503982A (en) 2002-03-28
ATE285762T1 (de) 2005-01-15
CO4970816A1 (es) 2000-11-07
EP1045691B1 (en) 2004-12-29
WO1999030704A1 (en) 1999-06-24
DE69828442D1 (de) 2005-02-03
DK1045691T3 (da) 2005-03-14
SV1998000146A (es) 1999-09-30
HN1998000185A (es) 1999-06-02
EP1045691A1 (en) 2000-10-25
PE20000017A1 (es) 2000-01-20
PT1045691E (pt) 2005-03-31
GT199800196A (es) 2000-06-03
CR5926A (es) 2000-03-06
CA2304612A1 (en) 1999-06-24
NO20002966D0 (no) 2000-06-09
CU20000140A7 (es) 2005-10-19
MY118381A (en) 2004-10-30
BR9813542A (pt) 2000-10-10
AR017851A1 (es) 2001-10-24
JP2002508320A (ja) 2002-03-19
PL341066A1 (en) 2001-03-26
DE69828442T2 (de) 2005-06-02
PA8464601A1 (es) 2001-12-14
KR20010033003A (ko) 2001-04-25
ES2230733T3 (es) 2005-05-01
AU1591599A (en) 1999-07-05
IS5445A (is) 2000-04-14
HUP0004547A2 (hu) 2001-05-28
NO20002966L (no) 2000-06-09
AU754089B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
IS5445A (is) Statín-karboxýalkýleter-blöndur
DE59804631D1 (de) Diketopyrrolopyrrolzusammensetzungen
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59803185D1 (de) Baulaser
DE59710388D1 (de) Mikropolarimeter
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59805979D1 (de) Organosilan-oligomere
ATA111897A (de) Kimme
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE59804377D1 (de) Kryoventil
DE59805424D1 (de) Transversalmodenresonatorfilter
DE59806025D1 (de) Normalsäschar
DE59805053D1 (de) Bogenflexodruckmaschine
ATA86797A (de) Verschleissschuh
DE59805451D1 (de) Coilboxofen
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
ATA46498A (de) Kunststoffgleitbahn
BR9703453A (pt) Projeto junça
ATE421585T1 (de) Motlinhomologe
DE59806103D1 (de) Pigmentgranulierung